Want to join the conversation?
For FY16, $BDX continues to estimate currency-neutral adjusted revenues, including the accretion from CareFusion acquisition, to increase 24.5-25.0%. The company raised its FY16 adjusted diluted EPS guidance to be between $8.50-8.57, up approx. 19.0-20.0%. As reported, $BDX expects diluted EPS to be between $6.14-6.21 for FY16.
Impressed with $AMZN’s latest grocery ambitions. The new Amazon Go convenience store, is an absolute game changer.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !